John Loper
Friday, June 23, 2017
FDA Clears Betrixaban (Bevyxxa) for VTE Prophylaxis
Betrixaban is the first and only anticoagulant for hospital and extended-duration prophylaxis of VTE in hospitalized, acutely medically ill patients at risk for VTE.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment